Multidrug resistance (MDR) in cancer - Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

Author： Krishna R.   Mayer L.D.  

Publisher： Elsevier

ISSN： 0928-0987

Source： European Journal of Pharmaceutical Sciences, Vol.11, Iss.4, 2000-10, pp. : 265-283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heterocyclic Compounds as MDR Modulators

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 2, 2011-02 ,pp. : 102-113

Bentham Science Publishers

Access to resources Recommend Favorite

An Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer Chemotherapy

By  

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 273-286

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Multidrug Resistance to Antitumor Agents (MDR)

By  

Current Medicinal Chemistry, Vol. 9, Iss. 2, 2002-01 ,pp. : 159-193

Bentham Science Publishers

Access to resources Recommend Favorite

MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug Resistance

By  

Current Drug Targets, Vol. 7, Iss. 7, 2006-07 ,pp. : 813-821

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule Inhibitors of Multidrug Resistance Gene (MDR1) Expression: Preclinical Evaluation and Mechanisms of Action

By  

Current Cancer Drug Targets, Vol. 13, Iss. 8, 2013-10 ,pp. : 814-828

Bentham Science Publishers

Access to resources Recommend Favorite